Venture Visionary Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.56M Buy
80,609
+19,110
+31% +$1.32M 0.21% 114
2025
Q1
$4.27M Buy
61,499
+57,812
+1,568% +$4.01M 0.18% 126
2024
Q4
$317K Sell
3,687
-2,200
-37% -$189K 0.01% 442
2024
Q3
$701K Buy
5,887
+68
+1% +$8.1K 0.03% 319
2024
Q2
$831K Buy
5,819
+1,901
+49% +$271K 0.04% 300
2024
Q1
$503K Buy
3,918
+1,019
+35% +$131K 0.02% 373
2023
Q4
$300K Buy
2,899
+19
+0.7% +$1.97K 0.02% 428
2023
Q3
$262K Sell
2,880
-136
-5% -$12.4K 0.02% 429
2023
Q2
$244K Sell
3,016
-86
-3% -$6.96K 0.01% 443
2023
Q1
$247K Buy
3,102
+146
+5% +$11.6K 0.02% 437
2022
Q4
$200K Buy
+2,956
New +$200K 0.01% 453
2022
Q3
Sell
-3,244
Closed -$181K 1185
2022
Q2
$181K Buy
+3,244
New +$181K 0.01% 466